Lucid Genomics
partners.compatible_products_services
- partners.product_title:
- Lucid Genome Suite
- partners.product_description:
Lucid Genomics is a cloud-native secondary and tertiary analysis platform built from the ground up for long-read sequencing. We develop dedicated products for rare disease diagnostics, hereditary cancer, and pharmacogenomics. As nanopore sequencing scales, the real opportunity lies in uncovering what was previously invisible: structural variants, methylation patterns, repeat expansions, and dark genome regions. Lucid is a pioneer in long-read interpretation, combining proprietary prioritization algorithms with cutting-edge visualizations purpose-built for long-read data. Together with native variant calling, advanced phasing, and annotation, this delivers a validated path from sequencer to actionable insights. As trusted Oxford Nanopore partner, Lucid helps Clinical Labs, Researchers and Pharma innovators to realize the full promise of long-read genomics.
- partners.specific_use_application:
- Rare Disease, Pharmacogenomics, Hereditary Cancer
- partners.territory:
- Worldwide
